Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,2-o-isopropylidene-3-o-3'-(n',n'-dimethylamino-n-propyl)-d-glucofuranose
2. 3-o-(3-(dimethylamino)propyl)-1,2-o-(1-methylethylidene)- Alpha-d-glucofuranose
3. Amiprilose
4. Amiprilose Hydrochloride
5. Amprilose
6. Sm 1213
7. Sm-1213
8. Therafectin
1. Amiprilose Hydrochloride
2. 56824-20-5
3. (r)-1-((3ar,5r,6s,6ar)-6-(3-(dimethylamino)propoxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethane-1,2-diol Hydrochloride
| Molecular Weight | 341.83 g/mol |
|---|---|
| Molecular Formula | C14H28ClNO6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 341.1605153 g/mol |
| Monoisotopic Mass | 341.1605153 g/mol |
| Topological Polar Surface Area | 80.6 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 337 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
94
PharmaCompass offers a list of 56824-20-5 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 56824-20-5 manufacturer or 56824-20-5 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 56824-20-5 manufacturer or 56824-20-5 supplier.
PharmaCompass also assists you with knowing the 56824-20-5 API Price utilized in the formulation of products. 56824-20-5 API Price is not always fixed or binding as the 56824-20-5 Price is obtained through a variety of data sources. The 56824-20-5 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 56824-20-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 56824-20-5, including repackagers and relabelers. The FDA regulates 56824-20-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 56824-20-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 56824-20-5 supplier is an individual or a company that provides 56824-20-5 active pharmaceutical ingredient (API) or 56824-20-5 finished formulations upon request. The 56824-20-5 suppliers may include 56824-20-5 API manufacturers, exporters, distributors and traders.
56824-20-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 56824-20-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 56824-20-5 GMP manufacturer or 56824-20-5 GMP API supplier for your needs.
A 56824-20-5 CoA (Certificate of Analysis) is a formal document that attests to 56824-20-5's compliance with 56824-20-5 specifications and serves as a tool for batch-level quality control.
56824-20-5 CoA mostly includes findings from lab analyses of a specific batch. For each 56824-20-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
56824-20-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (56824-20-5 EP), 56824-20-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (56824-20-5 USP).
